Altered medial prefrontal cortex and dorsal raphé activity predict genotype and correlate with abnormal learning behavior in a mouse model of autism-associated 2p16.3 deletion.
Rebecca B Hughes, Jayde Whittingham-Dowd, Steven J Clapcote and 2 others
PMID 35142069WHAT IT FOUND
Mice with an autism-associated gene deletion learned new odor cues faster but struggled to switch rules when rewards changed.
This suggests the deletion affects different types of learning differently. These findings are from animal models and do not translate to human therapy.
Key findings
01The mice required fewer trials to learn the first odor discrimination, indicating enhanced learning of a novel association.
02The mice required significantly more trials to reach criterion during reversal learning, indicating a deficit in switching strategies.
03Metabolism in the medial prefrontal cortex and dorsal raphé nucleus differed between genotypes and helped predict which mice carried the deletion.
STILL TO COME
How it was doneWhat they found
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
This is an animal study using mice. The findings describe biological mechanisms in a specific genetic model and cannot be directly applied to human clinical practice or therapy. The learning tasks were odor-based. The authors note that human cognitive profiles in these disorders are often assessed using visual or auditory stimuli, so the specific type of learning enhancement may not generalize. Behavioral effects were sometimes sex-specific, with hyperactivity seen only in males, while anxiety-like behavior was seen in both sexes. The study identifies correlations between brain metabolism and behavior but does not prove that the metabolic changes cause the behavioral differences.
Declared interests
The authors declared no conflict of interest. The work was funded by Lancaster University.
The easy way to misread this
Do not assume these mice's enhanced odor learning translates to better learning abilities for human patients. The paper explicitly states the effects are domain-specific and this is a mechanistic animal model, not a clinical trial of therapy.